genscript cpass nab Search Results


genscript cpass nab  (GenScript corporation)
90
GenScript corporation genscript cpass nab
Receiver operating characteristic curves for cohort 3. Percent positive and negative agreement were computed for each assay pair, using the indicated assay as the reference assay. The Roche <t>anti-NC</t> <t>ECLIA</t> assay is represented by black dots, the Roche anti-S ECLIA assay by blue squares, the Ortho anti-S CLIA assay by green triangles, the Abbott anti-NC CLIA assay by orange inverted triangles, and the Genscript <t>cPass</t> nAb by pink plus signs. Areas under the curve (AUCs) can be found in Table S3.
Genscript Cpass Nab, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/genscript cpass nab/product/GenScript corporation
Average 90 stars, based on 1 article reviews
genscript cpass nab - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
cpass nab elisa assay  (GenScript corporation)
90
GenScript corporation cpass nab elisa assay
Receiver operating characteristic curves for cohort 3. Percent positive and negative agreement were computed for each assay pair, using the indicated assay as the reference assay. The Roche <t>anti-NC</t> <t>ECLIA</t> assay is represented by black dots, the Roche anti-S ECLIA assay by blue squares, the Ortho anti-S CLIA assay by green triangles, the Abbott anti-NC CLIA assay by orange inverted triangles, and the Genscript <t>cPass</t> nAb by pink plus signs. Areas under the curve (AUCs) can be found in Table S3.
Cpass Nab Elisa Assay, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cpass nab elisa assay/product/GenScript corporation
Average 90 stars, based on 1 article reviews
cpass nab elisa assay - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


Receiver operating characteristic curves for cohort 3. Percent positive and negative agreement were computed for each assay pair, using the indicated assay as the reference assay. The Roche anti-NC ECLIA assay is represented by black dots, the Roche anti-S ECLIA assay by blue squares, the Ortho anti-S CLIA assay by green triangles, the Abbott anti-NC CLIA assay by orange inverted triangles, and the Genscript cPass nAb by pink plus signs. Areas under the curve (AUCs) can be found in Table S3.

Journal: Microbiology Spectrum

Article Title: Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds

doi: 10.1128/spectrum.01154-22

Figure Lengend Snippet: Receiver operating characteristic curves for cohort 3. Percent positive and negative agreement were computed for each assay pair, using the indicated assay as the reference assay. The Roche anti-NC ECLIA assay is represented by black dots, the Roche anti-S ECLIA assay by blue squares, the Ortho anti-S CLIA assay by green triangles, the Abbott anti-NC CLIA assay by orange inverted triangles, and the Genscript cPass nAb by pink plus signs. Areas under the curve (AUCs) can be found in Table S3.

Article Snippet: Correlation, as determined by Spearman’s Rho, ranged from 0.61 when comparing the Roche anti-NC ECLIA and Genscript cPass nAb assays to 0.92 when comparing the Ortho anti-S IgG CLIA and Genscript cPass nAb assays.

Techniques:

Positivity and EUA high-titer cutoffs for the SARS-CoV-2 serologic assays used

Journal: Microbiology Spectrum

Article Title: Limited Correlation between SARS-CoV-2 Serologic Assays for Identification of High-Titer COVID-19 Convalescent Plasma Using FDA Thresholds

doi: 10.1128/spectrum.01154-22

Figure Lengend Snippet: Positivity and EUA high-titer cutoffs for the SARS-CoV-2 serologic assays used

Article Snippet: Correlation, as determined by Spearman’s Rho, ranged from 0.61 when comparing the Roche anti-NC ECLIA and Genscript cPass nAb assays to 0.92 when comparing the Ortho anti-S IgG CLIA and Genscript cPass nAb assays.

Techniques: Neutralization, Inhibition